en

PRODUCT DETAIL

Hulio 40 mg injekčný roztok v naplnenej injekčnej striekačke

Code 9021D
MA number EU/1/18/1319/011
Product Form: sol inj 1x0,8 ml/40 mg (striek.inj.napl.plast.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Biosimilar Collaborations Ireland Limited, Ireland
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors
L04AB04 Adalimumab
Shelf life: 36
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 17.09.2018
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 09.08.2023
eu-flag.png sk-flag.png